Expression of interleukin-12 is increased in psoriatic skin.
暂无分享,去创建一个
N. Yawalkar | L. Braathen | C. Brand | R. Hunger | L R Braathen | S. Karlen | S Karlen | N Yawalkar | R Hunger | C U Brand | R. Hunger
[1] L. Adorini,et al. Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases. , 1997, Chemical immunology.
[2] J. Garioch,et al. Restricted T‐cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis , 1993, The British journal of dermatology.
[3] W Sterry,et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. , 1998, The Journal of clinical investigation.
[4] M. Fey,et al. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. , 1995, Blood.
[5] D. Macdonald,et al. Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-gamma. , 1993, The American journal of pathology.
[6] M. Heng,et al. Cell interactions in psoriasis. , 1985, Archives of dermatology.
[7] I. Jónsdóttir,et al. Circulating T Cells of Patients with Active Psoriasis Respond to Streptococcal M‐Peptides Sharing Sequences with Human Epidermal Keratins , 1997, Scandinavian journal of immunology.
[8] E. Minshall,et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. , 1996, The Journal of allergy and clinical immunology.
[9] E. Christophers. The immunopathology of psoriasis. , 1996, International archives of allergy and immunology.
[10] H. Valdimarsson,et al. Epidermal T lymphocytes and HLA‐DR expression in psoriasis , 1984, The British journal of dermatology.
[11] A. Menssen,et al. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. , 1995, Journal of immunology.
[12] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.
[13] A. Lanzavecchia,et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.
[14] G. Rassner,et al. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. , 1990, Archives of dermatology.
[15] G. Trinchieri,et al. Immunomodulatory functions and molecular regulation of IL-12. , 1997, Chemical immunology.
[16] N. Yawalkar,et al. Constitutive expression of both subunits of interleukin-12 in human keratinocytes. , 1996, The Journal of investigative dermatology.
[17] Richard E. Goodman,et al. Interleukin 12: A Potential Link between Nerve Cells and the Immune Response in Inflammatory Disorders , 1995, Molecular medicine.
[18] L. Kowalzick,et al. Psoriasis induced at the injection site of recombinant interferons. , 1990, Archives of dermatology.
[19] H. Nariuchi,et al. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. , 1996, Journal of immunology.
[20] J. Travers,et al. Lymphocyte activation in the pathogenesis of psoriasis. , 1997, The Journal of investigative dermatology.
[21] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[22] W. Jochum,et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.
[23] N. Romani,et al. High Level IL-12 Product ion by Murine Dendrit ic Cells : Upregulation via MHC Class II and CD 40 Molecules and Downregulat ion by IL-4 and IL-10 By , 2003 .
[24] I. Jónsdóttir,et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.
[25] M. Degré,et al. Interferon in suction blister fluid from psoriatic lesions , 1983, The British journal of dermatology.
[26] C. Maliszewski,et al. Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.
[27] P. Kerkhof,et al. Transition from symptomless to lesional psoriatic skin , 1996, Clinical and experimental dermatology.
[28] A. Menssen,et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[29] L. Picker,et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production , 1995, The Journal of experimental medicine.
[30] M. Gately,et al. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. , 1998, Journal of immunology.